XNPT 7.68 Xenoport Inc $XNPT Hit a 52 week high of 7.72

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
XNPT 7.68 Xenoport Inc $XNPT Hit a 52 week high of 7.72 Closing the day 09:44 at 7.68 -0.03 -0.39% With a day low of 7.58 and a total volume of 19,196.

XNPT Recent Posts: http://investorshangout.com/XenoPort-Inc-XNPT-55935/

XNPT Xenoport Inc Recent Headline News

XenoPort's (XNPT) CEO Ron Barrett Presents at Credit Suisse Healthcare Conference (Transcript)
SA Transcripts - at Seeking Alpha - 28 mins ago

XNPT: 7.88 (+0.17)

Can the Uptrend Continue for XenoPort (XNPT)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:33AM CST
Can the Uptrend Continue for XenoPort (XNPT)?
XNPT: 7.88 (+0.17)

XenoPort to Present at the Credit Suisse Healthcare Conference
Business Wire - Thu Nov 06, 12:09PM CST
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2014 Credit Suisse Healthcare Conference in Phoenix, Arizona. The live presentation will occur at 8:30 a.m. Pacific Time (9:30 a.m. Mountain Time) on Wednesday, November 12, 2014. A replay of the presentation will also be available.
XNPT: 7.88 (+0.17)

XenoPort Has Returned 39.6% Since SmarTrend Recommendation (XNPT)
Comtex SmarTrend(R) - Wed Nov 05, 11:04AM CST
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 2 months, XenoPort has returned 39.59% as of today's recent price of $7.21.
XNPT: 7.88 (+0.17)

XenoPort's (XNPT) CEO Ron Barrett on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 9:40PM CST

XNPT: 7.88 (+0.17)

XenoPort (XNPT) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 3:55PM CST

XNPT: 7.88 (+0.17)

XenoPort beats by $0.49, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:27PM CST

XNPT: 7.88 (+0.17)

XenoPort Reports Third Quarter Financial Results
Business Wire - Tue Nov 04, 3:07PM CST
XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2014. Revenues for the third quarter were $31.1 million compared to $2.5 million for the same period in 2013. Revenues for the third quarter included $25.0 million in collaboration revenue resulting from XenoPort's license agreement with Reckitt Benckiser Pharmaceuticals, Inc. Net income for the third quarter was $8.3 million compared to a net loss of $18.8 million for the same period in 2013. At September 30, 2014, XenoPort had cash, cash equivalents and short-term investments of $113.4 million.
XNPT: 7.88 (+0.17)

XNPT, AMRS, GSAT, CRDC, IOSP, OKS Expected To Be Down After Next Earnings Releases
M2 - Mon Nov 03, 3:33AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, November 4th 2014 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and December earnings reports. Xenoport Inc (NASDAQ:XNPT), AMYRIS INC (NASDAQ:AMRS), Globalstar Inc (OTC:GSAT), Cardica Inc (NASDAQ:CRDC), INNOSPEC INC. (NASDAQ:IOSP), ONEOK PARTNERS, L.P. (NYSE:OKS) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Tuesday:
AMRS: 2.89 (+0.06), IOSP: 44.22 (+0.33), OKE: 56.56 (+0.31), CRDC: 0.86 (-0.01), OKS: 48.17 (+0.67), GSAT: 2.72 (+0.12), XNPT: 7.88 (+0.17)

XenoPort Up 32.4% Since SmarTrend Uptrend Call (XNPT)
Comtex SmarTrend(R) - Wed Oct 29, 9:38AM CDT
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 2 months, XenoPort has returned 32.43% as of today's recent price of $6.84.
XNPT: 7.88 (+0.17)

XenoPort reports November 4
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 10:53AM CDT

XNPT: 7.88 (+0.17)

XenoPort to Release Third Quarter Financial Results on November 4
Business Wire - Thu Oct 23, 9:00AM CDT
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 4, 2014 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A replay of the call will be available for one week following the event.
XNPT: 7.88 (+0.17)

XenoPort Shares Up 22.6% Since SmarTrend's Buy Recommendation (XNPT)
Comtex SmarTrend(R) - Wed Oct 22, 9:18AM CDT
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 2 months, XenoPort has returned 22.56% as of today's recent price of $6.33.
XNPT: 7.88 (+0.17)

Uptrend Call Working As XenoPort Stock Rises 20.2% (XNPT)
Comtex SmarTrend(R) - Tue Oct 14, 5:17PM CDT
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 2 months, XenoPort has returned 20.23% as of today's recent price of $6.21.
XNPT: 7.88 (+0.17)

Commit To Buy XenoPort At $5, Earn 15.8% Annualized Using Options
StockOptionsChannel.com - Thu Oct 09, 10:29AM CDT
Investors eyeing a purchase of XenoPort Inc shares, but tentative about paying the going market price of $5.82/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
XNPT: 7.88 (+0.17)

Anacor Pharmaceuticals Appoints Wendell Wierenga to Its Board of Directors
Business Wire - Fri Sep 12, 7:30AM CDT
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that its Board of Directors has appointed Wendell Wierenga, Ph.D. to serve as a Class III director until the Company's 2016 annual meeting of shareholders. Anacor also announced that Paul Klingenstein has resigned from the Board.
CYTK: 4.30 (-0.09), SNTS: (), OCRX: 5.59 (+0.06), ANAC: 31.58 (+0.30), XNPT: 7.88 (+0.17)

Xenoport/NIAAA Collaborate on Alcoholism Therapy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 3:55PM CDT
Xenoport, Inc. (XNPT) entered into a clinical trial collaboration agreement with the National Institute on Alcohol Abuse and Alcoholism, for a study that will evaluate HORIZANT as a potential treatment for alcohol use disorder (AUD).
CBPO: 68.75 (+2.47), CBM: 23.88 (+0.37), AMGN: 161.93 (-0.49), XNPT: 7.88 (+0.17)

XenoPort to Present Data for Novel Fumarate Analog XP23829 at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston
Business Wire - Wed Sep 10, 7:30AM CDT
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data on XP23829, an investigational prodrug of monomethyl fumarate (MMF), at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston. Data being presented include the results from a clinical trial evaluating the safety, tolerability and pharmacokinetics of XP23829.
XNPT: 7.88 (+0.17)

XenoPort and the NIAAA Announce Clinical Trial Agreement to Study HORIZANT as a Potential Treatment for Alcohol Use Disorder
Business Wire - Tue Sep 09, 7:30AM CDT
XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that they have entered into an agreement to conduct a clinical trial of HORIZANT(R) (gabapentin enacarbil) Extended-Release Tablets as a potential treatment for alcohol use disorder (AUD). Under the terms of the agreement, XenoPort will supply clinical trial material and the NIAAA will conduct and pay all other expenses associated with the proposed clinical trial of HORIZANT. XenoPort will have access to study results generated under the proposed clinical trial to support potential regulatory filings for HORIZANT.
XNPT: 7.88 (+0.17)

DTSI, XNPT, ZUMZ, BIDU, DISCA, KBE Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Sep 04, 9:30AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of DTS, INC. (NASDAQ TSI), Xenoport Inc (NASDAQ:XNPT), Zumiez Inc (NASDAQ:ZUMZ), Baidu Inc (NASDAQ:BIDU), Discovery Communications Inc (NASDAQ ISCA), Kbw Bank Etf (NYSE:KBE) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ZUMZ: 35.63 (+1.69), DTSI: 33.50 (+0.21), KBE: 33.86 (+0.34), BIDU: 249.87 (-0.47), DISCA: 31.79 (-0.20), XNPT: 7.88 (+0.17)

XenoPort Inc (XNPT) Stock Research Links

XNPT Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LKQ’s Europe ERP Mess Turns Into a Credibility Test

Updated Category News Views 98

A software rollout should not be able to punch a company in the teeth twice, yet LKQ shareholders have watched precisely that ugly movie in 2026. The October 23 disclosure was a real gut-check: an immediate CEO departure, a $16 million net loss, and renewed acknowledgement that the German enterprise-resource-planning rollout was disrupting Europe. Shares fell $5.05, or...

Continue Reading
NetEase Miss Opens an Investigation, Not a Verdict

Updated Category News Views 70

A two-dollar earnings gap can make a shareholder base jumpy fast, and NetEase just handed the market a rough set of numbers to chew on. The November 19 notice says NetEase's third-quarter 2026 report missed Wall Street expectations on both earnings and revenue, followed by a sharp decline in the shares. That has prompted SueWallSt, powered by Levi & Korsinsky LLP, to...

Continue Reading
Frost & Sullivan’s 65 Years Put APAC Growth on Display

Updated Category News Views 25

A Crowded Singapore Room Says Something Singapore did not host a mere anniversary toast on November 18; it hosted a pretty revealing cross-section of the businesses trying to build, secure, cool, connect, finance, and digitize Asia Pacific and MEASA. Frost & Sullivan marked 65 years with its 2026 Best Practices Recognition banquet at Hilton Singapore Orchard, gathering...

Continue Reading
Anduin Opens Its Investor Portal Beyond Early Users

Updated Category News Views 30

Private-market paperwork has long been a swamp of portals, PDFs, email chains, and somebody chasing down a wire change at the worst possible moment. Anduin is taking a swing at that mess by opening its Investor Portal to all customers after building it with leading asset managers and operating it with their investors. The pitch is sensible: give limited partners one...

Continue Reading
Shareholder Votes Clear ODNB-NACB Merger's Final Hurdle

Updated Category News Views 69

A merger vote rarely makes anyone pound the table, but it does remove one very real way a bank deal can stumble. ODNB Financial Corporation and National Capital Bancorp, Inc. have announced that their shareholders approved the proposed merger. That is meaningful progress, plain and simple. It says the owners who get to live with the outcome have signed off on joining the...

Continue Reading
SwitchBot's Black Friday Sale Tests Smart Home Demand

Updated Category News Views 147

Holiday gadget season is where clever home-tech pitches either earn their keep or gather dust in a warehouse. SwitchBot is coming into Black Friday 2026 with discounts of up to 50% on select products, running from November 19 through Cyber Monday on November 30. The lineup is broad enough to matter: decorative color E Ink frames, automated curtains and blinds, an indoor...

Continue Reading
Adcendo’s Early Sarcoma Data Earns a Careful Look

Updated Category News Views 71

Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...

Continue Reading
MemorialCare Adds AI Guardrails for Hidden Aneurysms

Updated Category News Views 91

A brain scan ordered for one reason can suddenly expose a risk nobody knew was sitting there. That is the sober promise behind MemorialCare Neuroscience Institute's rollout of Rapid Aneurysm, an artificial-intelligence tool embedded in qualifying CTA and MRA brain scans across its inpatient and outpatient network. MemorialCare says it is the first health system in Los...

Continue Reading
Decibel's Export Engine Masks a Domestic Sales Slip

Updated Category News Views 118

Decibel’s overseas business is doing the heavy lifting, and it is not doing it quietly. Third-quarter net revenue reached $35.1 million, up 7% from a year earlier, while international sales jumped 44% to a record $12.1 million. That split matters more than the headline. Canadian adult-use sales fell 6% to $23.0 million, which means the company is proving it can find...

Continue Reading
Candel’s BLA Delay Puts Disclosure Timing Under Fire

Updated Category News Views 118

A December filing turned into a mid-2027 wait, and Candel shareholders absorbed the damage in one ugly trading session. On November 13, shares of Candel Therapeutics fell 26% after the company disclosed that its biologics license application, or BLA, for aglatimagene in prostate cancer was no longer expected in December 2026. The revised plan is to submit in the middle of...

Continue Reading

Top 5 Most Recently Viewed Articles

Uncovering Surveillance Pricing: Consumer Watchdog's New Insights

Updated Category News Views 124

Understanding Surveillance Pricing in Today's Market As we continue to navigate the digital landscape, a new and concerning practice has emerged within the retail and e-commerce sectors — surveillance pricing. This strategy allows corporations to charge different prices to consumers for the same item based on their personal data and online behavior, as highlighted by...

Continue Reading
Understanding Voting Rights and Capital at Albion Technology

Updated Category News Views 136

Total Voting Rights and Capital Overview Albion Technology & General VCT PLC In accordance with Disclosure Guidance and Transparency Rule 5.6.1, we at Albion Technology & General VCT PLC are providing key insights into our voting rights and capital structure. Issued Share Capital Details As of the recent update, the issued share capital and voting rights of the Company...

Continue Reading
Hisense Unveils Cutting-Edge Smart Home Solutions at IFA

Updated Category News Views 130

Transforming Everyday Living with Hisense Smart Technology Leading the way in home technology, Hisense recently showcased a range of innovative smart home solutions designed to enhance daily living at the IFA 2024 trade show. As a prominent name in consumer electronics, Hisense is committed to elevating the smart living experience for users worldwide. Hisense's Dedication...

Continue Reading
Jeffs’ Brands Enters Strategic Agreement for Security Tech Expansion

Updated Category News Views 296

Exploring New Horizons: Jeffs’ Brands' Non-Binding MOU The 3D, AI-Powered Technology Screens 25,000 People Per Hour—Without Stopping Them In an exciting development for Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (NASDAQ: JFBR, JFBRW), a leading data-driven e-commerce firm leveraging the Amazon Marketplace, the company has announced its wholly owned...

Continue Reading
Garmin and Global Researchers Unveil Groundbreaking Happiness Study

Updated Category News Views 175

Introduction to the Health and Happiness Study Garmin, known for its innovative technology, has embarked on an exciting journey in collaboration with researchers from prestigious institutions aimed at understanding the intricate relationship between technology, happiness, and wellbeing. This Health and Happiness Study represents a significant step forward in the quest to...

Continue Reading